BioMarin Pharmaceuticals BMRN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.07B+134% | $1.31B+4.9% | $1.25B+3.0% | $1.21B+15.7% | $1.05B+11.2% | ||
| $0-100% | $248.93M+9.3% | $227.73M+4.3% | $218.31M-2.3% | $223.53M+14.7% | ||
| $903.91M-0.5% | $908.21M+14.9% | $790.27M-7.7% | $855.86M+15.8% | $739.18M+11.9% | ||
| $1.27B-2.0% | $1.3B-6.0% | $1.38B+3.1% | $1.34B+5.1% | $1.27B+3.4% | ||
| $97.85M-8.1% | $106.51M-7.6% | $115.3M-3.7% | $119.75M-26.3% | $162.49M+5.3% | ||
| $1.05B+31.7% | $801.06M+2.5% | $781.17M+5.6% | $739.52M+15.0% | $642.99M+16.8% | ||
| $120.76M-69.1% | $391.31M-19.4% | $485.7M+1.0% | $480.89M+2.5% | $469.36M-11.0% | ||
| $205.5M+10.6% | $185.78M-9.0% | $204.27M+15.3% | $177.18M-2.4% | $181.55M-9.9% | ||
| $4.61B+16.5% | $3.95B+2.6% | $3.85B+1.3% | $3.81B+9.7% | $3.47B+7.3% | ||
| $958.07M+0.6% | $952.51M-8.3% | $1.04B+0.8% | $1.03B-0.2% | $1.03B-1.0% | ||
| $1.09B+1.9% | $1.07B+13.1% | $949.66M+2.0% | $931.02M+2.5% | $908.19M+1.8% | ||
| $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | ||
| $204.66M-4.3% | $213.84M-8.3% | $233.11M-2.7% | $239.62M-3.1% | $247.35M-3.1% | ||
| $1.5B-0.5% | $1.51B0.0% | $1.51B+5.8% | $1.43B-2.3% | $1.46B-1.9% | ||
| $276.42M-0.2% | $277.05M+2.3% | $270.78M+8.7% | $249.19M+5.7% | $235.65M-6.3% | ||
| $0-100% | $492.24M-4.0% | $512.94M+0.9% | $508.59M+0.4% | $506.72M-2.8% | ||
| $8.59B+13.1% | $7.59B-0.3% | $7.61B+2.1% | $7.46B+4.3% | $7.15B+2.3% | ||
| $793.15M+4.5% | $759.03M-4.9% | $798.44M+16.7% | $684.25M+8.9% | $628.21M+3.5% | ||
| $152.61M-30.4% | $219.42M+23.4% | $177.76M+48.9% | $119.41M-8.3% | $130.23M-35.7% | ||
| $3.01M-17.9% | $3.67M-83.8% | $22.61M+68.7% | $13.4M-44.0% | $23.94M+90.5% | ||
| —— | —— | —— | —— | —— | ||
| $793.15M+4.5% | $759.03M-4.9% | $798.44M+16.7% | $684.25M+8.9% | $628.21M+3.5% | ||
| $1.43B+140% | $597.18M— | —— | —— | —— | ||
| $155.48M+3.1% | $150.82M-7.5% | $163.06M+9.6% | $148.82M+14.8% | $129.69M+0.7% | ||
| $2.38B+57.9% | $1.51B-3.3% | $1.56B+9.0% | $1.43B+5.6% | $1.35B+1.7% | ||
| 500M0.0% | 500M0.0% | 500M0.0% | 500M0.0% | 500M+261,680% | ||
| $5.97B+0.2% | $5.96B+0.9% | $5.9B+0.8% | $5.85B+1.0% | $5.79B-0.1% | ||
| $259.73M+68.4% | $154.21M-23.2% | $200.78M-13.3% | $231.52M+2,670% | -$9.01M+95.4% | ||
| -$4.24M+68.6% | -$13.47M+60.3% | -$33.94M+23.8% | -$44.57M-333% | $19.15M-68.9% | ||
| $6.21B+2.1% | $6.09B+0.5% | $6.06B+0.5% | $6.03B+4.0% | $5.79B+2.4% | ||
| $8.59B+13.1% | $7.59B-0.3% | $7.61B+2.1% | $7.46B+4.3% | $7.15B+2.3% | ||
| $3.07B+50.0% | $2.05B+3.1% | $1.99B+2.6% | $1.94B+9.1% | $1.78B+7.2% | ||
| $3.07B+49.7% | $2.05B+3.1% | $1.99B+2.6% | $1.94B+9.1% | $1.78B+7.2% | ||
| $0-100% | $248.93M+9.3% | $227.73M+4.3% | $218.31M-2.3% | $223.53M+14.7% | ||
| $120.76M-69.1% | $391.31M-19.4% | $485.7M+1.0% | $480.89M+2.5% | $469.36M-11.0% | ||
| $205.5M+10.6% | $185.78M-9.0% | $204.27M+15.3% | $177.18M-2.4% | $181.55M-9.9% | ||
| $35.06M+36.7% | $25.66M+4.3% | $24.59M+8.3% | $22.72M-39.4% | $37.47M-52.9% | ||
| $276.42M-0.2% | $277.05M+2.3% | $270.78M+8.7% | $249.19M+5.7% | $235.65M-6.3% | ||
| $722.36M-0.2% | $723.97M+0.2% | $722.74M+0.2% | $721.32M0.0% | $721.11M0.0% | ||
| $3.07B+50.0% | $2.05B+3.1% | $1.99B+2.6% | $1.94B+9.1% | $1.78B+7.2% | ||
| $0-100% | $492.24M-4.0% | $512.94M+0.9% | $508.59M+0.4% | $506.72M-2.8% | ||
| $1.5B-0.5% | $1.51B0.0% | $1.51B+5.8% | $1.43B-2.3% | $1.46B-1.9% | ||
| $204.66M-4.3% | $213.84M-8.3% | $233.11M-2.7% | $239.62M-3.1% | $247.35M-3.1% | ||
| $204.66M-4.3% | $213.84M-8.3% | $233.11M-2.7% | $239.62M-3.1% | $247.35M-3.1% | ||
| $276.42M-0.2% | $277.05M+2.3% | $270.78M+8.7% | $249.19M+5.7% | $235.65M-6.3% | ||
| $2.05B+1.3% | $2.03B+2.0% | $1.99B+1.3% | $1.96B+1.1% | $1.94B+0.3% | ||
| $276.42M-0.2% | $277.05M+2.3% | $270.78M+8.7% | $249.19M+5.7% | $235.65M-6.3% | ||
| $395.47M+26.4% | $312.77M-19.7% | $389.67M+25.4% | $310.8M+5.8% | $293.75M+24.8% | ||
| $152.61M-30.4% | $219.42M+23.4% | $177.76M+48.9% | $119.41M-8.3% | $130.23M-35.7% | ||
| $6.66M-16.5% | $7.97M+14.7% | $6.95M-13.3% | $8.02M+2.0% | $7.86M-0.8% | ||
| $793.15M+4.5% | $759.03M-4.9% | $798.44M+16.7% | $684.25M+8.9% | $628.21M+3.5% | ||
| $3.01M-17.9% | $3.67M-83.8% | $22.61M+68.7% | $13.4M-44.0% | $23.94M+90.5% | ||
| $31.68M+2.2% | $31.01M-29.1% | $43.74M-20.9% | $55.31M+256% | $15.52M+18.8% | ||
| $152.61M-30.4% | $219.42M+23.4% | $177.76M+48.9% | $119.41M-8.3% | $130.23M-35.7% | ||
| $31.68M+2.2% | $31.01M-29.1% | $43.74M-20.9% | $55.31M+256% | $15.52M+18.8% | ||
| —— | —— | —— | —— | —— | ||
| $7.29M-5.1% | $7.68M-23.9% | $10.1M+56.6% | $6.45M-46.4% | $12.02M+68.9% | ||
| $1.43B+122% | $642.87M+7.1% | $600M0.0% | $600M0.0% | $600M+1,445% | ||
| —— | —— | —— | —— | —— | ||
| $10.45M-0.6% | $10.51M-6.9% | $11.29M-3.3% | $11.67M+4.4% | $11.18M-0.4% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 193.3M+0.5% | 192.3M+0.1% | 192.1M+0.1% | 192M+0.1% | 191.8M+0.5% | ||
| $5.97B+0.2% | $5.96B+0.9% | $5.9B+0.8% | $5.85B+1.0% | $5.79B-0.1% | ||
| $193K+0.5% | $192K0.0% | $192K0.0% | $192K0.0% | $192K+0.5% | ||
| $0-100% | $4.9M-0.6% | $4.93M+14.5% | $4.31M+6.6% | $4.05M+29.2% | ||
| $0-100% | $8K-85.5% | $55K-48.1% | $106K-56.7% | $245K-68.1% | ||
| $3.07B+50.0% | $2.05B+3.1% | $1.99B+2.6% | $1.94B+9.1% | $1.78B+7.2% | ||
| $38.58M-5.7% | $40.91M-30.1% | $58.54M-18.7% | $72M+332% | $16.66M+6.8% | ||
| $38.58M-5.7% | $40.91M-30.1% | $58.54M-18.7% | $72M+332% | $16.66M+6.8% | ||
| $177.66M+6.4% | $166.93M+19.2% | $140.05M-14.2% | $163.17M+17.7% | $138.59M+14.7% | ||
| $6.66M-16.5% | $7.97M+14.7% | $6.95M-13.3% | $8.02M+2.0% | $7.86M-0.8% | ||
| $0-100% | $8K-85.5% | $55K-48.1% | $106K-56.7% | $245K-68.1% | ||
| $0-100% | $4.9M-0.6% | $4.93M+14.5% | $4.31M+6.6% | $4.05M+29.2% | ||
| $3.07B+50.0% | $2.05B+3.1% | $1.99B+2.6% | $1.94B+9.1% | $1.78B+7.2% | ||
| $3.07B+49.7% | $2.05B+3.1% | $1.99B+2.6% | $1.94B+9.1% | $1.78B+7.2% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $500M0.0% | $500M0.0% | $500M0.0% | $500M0.0% | $500M0.0% | ||
| $193.27M+0.5% | $192.3M+0.1% | $192.1M+0.1% | $192M+0.1% | $191.76M+0.5% | ||
| $193.27M+0.5% | $192.3M+0.1% | $192.1M+0.1% | $192M+0.1% | $191.76M+0.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $35.06M+36.7% | $25.66M+4.3% | $24.59M+8.3% | $22.72M-39.4% | $37.47M-52.9% | ||
| $38.58M-5.7% | $40.91M-30.1% | $58.54M-18.7% | $72M+332% | $16.66M+6.8% | ||
| $517.7M+1.5% | $510.13M+4.2% | $489.63M+1.6% | $481.7M+1.7% | $473.76M+1.7% | ||
| $722.36M-0.2% | $723.97M+0.2% | $722.74M+0.2% | $721.32M0.0% | $721.11M0.0% | ||
| $9.32M+7.3% | $8.69M+14.6% | $7.58M-1.6% | $7.7M+22.1% | $6.31M-16.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) holds $8.6B in total assets, up 20.2% year over year.
- How much debt does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals carries $1.4B in total debt against $6.2B of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals holds $3.1B in cash and equivalents.
- Can BioMarin Pharmaceuticals cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does BioMarin Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
